D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 81 Citations 23,098 284 World Ranking 970 National Ranking 31
Medicine D-index 81 Citations 23,321 309 World Ranking 11397 National Ranking 391

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Cancer

Filippo Belardelli focuses on Immunology, Immune system, Cytokine, Interferon and Dendritic cell. His study in Acquired immune system, Virus, CC chemokine receptors, Monocyte and Interferon type I is carried out as part of his Immunology studies. The study incorporates disciplines such as Cancer, Antibody and Alpha interferon in addition to Immune system.

Filippo Belardelli has included themes like T lymphocyte, Cellular differentiation, Host response, Immune regulation and CCL18 in his Cytokine study. His biological study spans a wide range of topics, including Cancer research, Peritoneal cavity, CXCL10, TLR3 and Pattern recognition receptor. His study in Dendritic cell is interdisciplinary in nature, drawing from both C-C chemokine receptor type 7, Interleukin 12, Interleukin 15 and Antigen-presenting cell.

His most cited work include:

  • Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. (869 citations)
  • Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice (679 citations)
  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (519 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Immune system, Interferon, Virology and Cell biology. His work in Immunology addresses issues such as Cancer, which are connected to fields such as Clinical trial. His Immune system study frequently intersects with other fields, such as Spleen.

His Interferon research includes themes of Molecular biology, Cancer research and Friend leukemia. His Virology research incorporates elements of Adjuvant, In vitro and Antibody. His work carried out in the field of Cell biology brings together such families of science as Receptor, IL-2 receptor and Cellular differentiation.

He most often published in these fields:

  • Immunology (49.68%)
  • Immune system (27.85%)
  • Interferon (25.63%)

What were the highlights of his more recent work (between 2007-2021)?

  • Immunology (49.68%)
  • Immune system (27.85%)
  • Immunotherapy (14.56%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Immunology, Immune system, Immunotherapy, Cancer and Cell biology. Dendritic cell, Cancer immunotherapy, CD8, Antigen-presenting cell and Antigen are the primary areas of interest in his Immunology study. His studies in Immune system integrate themes in fields like Interferon, Cell and Melanoma.

The various areas that Filippo Belardelli examines in his Immunotherapy study include Combination therapy, Dacarbazine and Oncology. His research in Cancer intersects with topics in Cancer research, Clinical trial, Cyclophosphamide, Family medicine and Adjuvant. His research on Cell biology also deals with topics like

  • Antigen processing and related Cross-presentation,
  • IL-2 receptor that connect with fields like Priming,
  • In vitro that connect with fields like Spleen.

Between 2007 and 2021, his most popular works were:

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (519 citations)
  • Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer (436 citations)
  • Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis (224 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Cancer

Filippo Belardelli mostly deals with Immunology, Immune system, Cell biology, Immunotherapy and Acquired immune system. His Immunology research is multidisciplinary, relying on both Cancer and Cytotoxic T cell. His study in Immune system is interdisciplinary in nature, drawing from both Interferon, Melanoma and Cytokine.

His Cell biology research includes themes of In vitro, IL-2 receptor, CD40, Immunosurveillance and Transcription factor. Filippo Belardelli focuses mostly in the field of Immunotherapy, narrowing it down to topics relating to Dacarbazine and, in certain cases, T-cell receptor. The various areas that Filippo Belardelli examines in his Acquired immune system study include Chemokine, Innate immune system and Cell growth.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

Agnes Le Bon;Giovanna Schiavoni;Giuseppina D'Agostino;Ion Gresser.
Immunity (2001)

1135 Citations

Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

Stefano M. Santini;Caterina Lapenta;Mariantonia Logozzi;Stefania Parlato.
Journal of Experimental Medicine (2000)

1079 Citations

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

L Bracci;G Schiavoni;A Sistigu;F Belardelli.
Cell Death & Differentiation (2014)

850 Citations

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba.
Nature Medicine (2014)

809 Citations

Role of interferons and other cytokines in the regulation of the immune response.

Filippo Belardelli.
Apmis (1995)

622 Citations

Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Maria Montoya;Giovanna Schiavoni;Fabrizio Mattei;Ion Gresser.
Blood (2002)

611 Citations

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.

Fabrizio Mattei;Giovanna Schiavoni;Filippo Belardelli;David F. Tough.
Journal of Immunology (2001)

521 Citations

The neglected role of type I interferon in the T-cell response: implications for its clinical use

Filippo Belardelli;Ion Gresser.
Immunology Today (1996)

504 Citations

ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells

Giovanna Schiavoni;Fabrizio Mattei;Paola Sestili;Paola Borghi.
Journal of Experimental Medicine (2002)

472 Citations

Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs

Francesca Luciani;Massimo Spada;Angelo De Milito;Agnese Molinari.
Journal of the National Cancer Institute (2004)

468 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Filippo Belardelli

Laurence Zitvogel

Laurence Zitvogel

University of Paris-Saclay

Publications: 105

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 91

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 67

Stefano Fais

Stefano Fais

Istituto Superiore di Sanità

Publications: 62

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 37

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 37

Jacques Banchereau

Jacques Banchereau

Immunai

Publications: 33

Paul J. Hertzog

Paul J. Hertzog

Hudson Institute of Medical Research

Publications: 33

Sandra Gessani

Sandra Gessani

Istituto Superiore di Sanità

Publications: 31

Keiko Ozato

Keiko Ozato

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publications: 31

Lionel Apetoh

Lionel Apetoh

Grenoble Alpes University

Publications: 29

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 29

Marco Colonna

Marco Colonna

Washington University in St. Louis

Publications: 27

Takahiro Yamazaki

Takahiro Yamazaki

Cornell University

Publications: 27

Erika Vacchelli

Erika Vacchelli

Université Paris Cité

Publications: 27

Patrizia Agostinis

Patrizia Agostinis

KU Leuven

Publications: 25

Trending Scientists

Bart Baesens

Bart Baesens

KU Leuven

Salvatore Orlando

Salvatore Orlando

Ca Foscari University of Venice

John H. Holland

John H. Holland

University of Michigan–Ann Arbor

Marc Lemaire

Marc Lemaire

Claude Bernard University Lyon 1

Norman L. Allinger

Norman L. Allinger

University of Georgia

Yasutaka Kuwahara

Yasutaka Kuwahara

Osaka University

Nongjian Tao

Nongjian Tao

Arizona State University

Amit Misra

Amit Misra

University of Michigan–Ann Arbor

Ian Kaplan

Ian Kaplan

Purdue University West Lafayette

Arthur S. Tatham

Arthur S. Tatham

Cardiff Metropolitan University

Lucie Germain

Lucie Germain

Université Laval

Rolf Mentlein

Rolf Mentlein

Kiel University

James H. Swift

James H. Swift

University of California, San Diego

Gaylon S. Campbell

Gaylon S. Campbell

Decagon Devices

John B. Mulliken

John B. Mulliken

Boston Children's Hospital

Harold O. Conn

Harold O. Conn

Yale University

Something went wrong. Please try again later.